- Home
- AHG vs TKNO Comparison
AHG vs TKNO Comparison
Compare AHG & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AHG
- TKNO
- Stock Information
- Founded
- AHG 2013
- TKNO 1996
- Country
- AHG China
- TKNO United States
- Employees
- AHG N/A
- TKNO N/A
- Industry
- AHG Business Services
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- AHG Consumer Discretionary
- TKNO Health Care
- Exchange
- AHG Nasdaq
- TKNO Nasdaq
- Market Cap
- AHG 245.7M
- TKNO 244.7M
- IPO Year
- AHG N/A
- TKNO 2021
- Fundamental
- Price
- AHG $0.80
- TKNO $6.44
- Analyst Decision
- AHG
- TKNO Buy
- Analyst Count
- AHG 0
- TKNO 2
- Target Price
- AHG N/A
- TKNO $5.00
- AVG Volume (30 Days)
- AHG 16.3K
- TKNO 279.1K
- Earning Date
- AHG 11-22-2024
- TKNO 11-07-2024
- Dividend Yield
- AHG N/A
- TKNO N/A
- EPS Growth
- AHG N/A
- TKNO N/A
- EPS
- AHG N/A
- TKNO N/A
- Revenue
- AHG $2,414,338.00
- TKNO $36,347,000.00
- Revenue This Year
- AHG N/A
- TKNO $3.23
- Revenue Next Year
- AHG N/A
- TKNO $14.38
- P/E Ratio
- AHG N/A
- TKNO N/A
- Revenue Growth
- AHG N/A
- TKNO N/A
- 52 Week Low
- AHG $0.53
- TKNO $1.16
- 52 Week High
- AHG $2.90
- TKNO $7.92
- Technical
- Relative Strength Index (RSI)
- AHG 42.44
- TKNO 68.27
- Support Level
- AHG $0.90
- TKNO $6.52
- Resistance Level
- AHG $0.95
- TKNO $7.92
- Average True Range (ATR)
- AHG 0.07
- TKNO 0.59
- MACD
- AHG -0.00
- TKNO -0.01
- Stochastic Oscillator
- AHG 11.17
- TKNO 79.78
About AHG Akso Health Group ADS
Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.